Health Care

Healthy Returns: How competitive can Roche be in the weight loss drug market?

Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.

adminadmin
Sep 18, 2024 - 10:00
 0  15
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
Read More

Tags:

Previous Article

U.S. crude oil rises more than 1%, closes above $71 per barrel amid Fed rate cut...

Next Article

Rate cut is already baked into mortgage rates, says Rocket Companies CEO Varun K...

admin
admin

Related Posts

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

Healthy Returns: Weight loss drug race heats up with pi...

admin Nov 9, 2024  0  5

2 health stocks are buys. They've been beaten up enough on Trump's RFK Jr. pick for HHS

2 health stocks are buys. They've been beaten up enough...

admin Nov 19, 2024  0  13

These are America's 10 worst states for quality of life in 2024

These are America's 10 worst states for quality of life...

admin Jul 14, 2024  0  22